RU2017119949A - A method for the treatment of stenotic forms of Crohn's disease - Google Patents

A method for the treatment of stenotic forms of Crohn's disease Download PDF

Info

Publication number
RU2017119949A
RU2017119949A RU2017119949A RU2017119949A RU2017119949A RU 2017119949 A RU2017119949 A RU 2017119949A RU 2017119949 A RU2017119949 A RU 2017119949A RU 2017119949 A RU2017119949 A RU 2017119949A RU 2017119949 A RU2017119949 A RU 2017119949A
Authority
RU
Russia
Prior art keywords
stenotic
crohn
disease
treatment
forms
Prior art date
Application number
RU2017119949A
Other languages
Russian (ru)
Other versions
RU2017119949A3 (en
Inventor
Олег Владимирович Князев
Анатолий Георгиевич Коноплянников
Анна Валерьевна Каграманова
Сергей Германович Хомерики
Нина Александровна Фадеева
Анастасия Александровна Карпеева
Наталия Владимировна Орлова
Михаил Владимирович Павлов
Алла Эдуардовна Лычкова
Карина Кадиевна Носкова
Марина Владимировна Кирова
Асфольд Иванович Парфенов
Original Assignee
Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр им. А.С. Логинова Департамента здравоохранения города Москвы
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр им. А.С. Логинова Департамента здравоохранения города Москвы filed Critical Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр им. А.С. Логинова Департамента здравоохранения города Москвы
Priority to RU2017119949A priority Critical patent/RU2017119949A/en
Publication of RU2017119949A3 publication Critical patent/RU2017119949A3/ru
Publication of RU2017119949A publication Critical patent/RU2017119949A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (1)

Способ лечения стенотической формы болезни Крона путем лекарственной терапии, отличающийся тем, что применяют мезенхимальные стромальные клетки (МСК) костного мозга в дозе 120-140 млн аллогенных МСК в комбинации с инфликсимабом в дозе 2,5-3 мг/кг, причем культуру МСК вводят трижды в течение месяца с интервалом 1 неделя с повтором через 6 месяцев от момента первого введения МСК.A method of treating a stenotic form of Crohn’s disease by drug therapy, characterized in that they use bone marrow mesenchymal stromal cells (MSCs) at a dose of 120-140 million allogeneic MSCs in combination with infliximab at a dose of 2.5-3 mg / kg, and the MSC culture is administered three times a month with an interval of 1 week with a repeat of 6 months from the moment of the first introduction of MSCs.
RU2017119949A 2017-06-07 2017-06-07 A method for the treatment of stenotic forms of Crohn's disease RU2017119949A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2017119949A RU2017119949A (en) 2017-06-07 2017-06-07 A method for the treatment of stenotic forms of Crohn's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2017119949A RU2017119949A (en) 2017-06-07 2017-06-07 A method for the treatment of stenotic forms of Crohn's disease

Publications (2)

Publication Number Publication Date
RU2017119949A3 RU2017119949A3 (en) 2018-12-07
RU2017119949A true RU2017119949A (en) 2018-12-07

Family

ID=64577008

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017119949A RU2017119949A (en) 2017-06-07 2017-06-07 A method for the treatment of stenotic forms of Crohn's disease

Country Status (1)

Country Link
RU (1) RU2017119949A (en)

Also Published As

Publication number Publication date
RU2017119949A3 (en) 2018-12-07

Similar Documents

Publication Publication Date Title
MX2022006107A (en) Methods and compositions for dosing in adoptive cell therapy.
MX2017006312A (en) Methods for tumor treatment using cd3xcd20 bispecific antibody.
RU2017132877A (en) COMBINATION OF PD-1 ANTAGONIST AND ERIBULIN FOR CANCER TREATMENT
RU2014118741A (en) COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF THEIR APPLICATION
NZ606993A (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
RU2016151757A (en) PDL-1 AND PD-1 ANTAGONISTS FOR TREATMENT OF HPV-NEGATIVE CANCER FORMS
RU2017134443A (en) METHOD OF TREATMENT WITH USE OF TRADIPTANT
JP2019530706A5 (en)
JP2019532047A5 (en)
MX2023000187A (en) Dosing of vibegron for treatment of overactive bladder.
RU2014139955A (en) SCAN COMBINED THERAPY FOR GLIOBLASTOMA
RU2015115398A (en) N-acetyl-L-cysteine for use in in vitro fertilization
MX2017005163A (en) Onapristone extended-release compositions and methods.
EA200901064A1 (en) DRUG FOR THE TREATMENT OF INFLUENZA IN BIRDS
RU2017119949A (en) A method for the treatment of stenotic forms of Crohn's disease
RU2015139515A (en) COMBINED TREATMENT
EA201591603A1 (en) NEW THERAPEUTIC COMBINATIONS MYRTAZAPINE FOR APPLICATION IN PAIN DISEASES
MX2021008941A (en) Gpr35 modulators.
Lunning et al. Modified SMILE in the treatment of natural killer T-cell lymphoma, nasal and nasal type: a single center US experience
Khodadoust Headache and increased SGOT and SGPT: case report
RU2014120624A (en) METHOD FOR TREATING A STROKE
RU2014102028A (en) PRODUCT FOR TREATMENT OF CHILDREN WITH ROTAVIRUS INFECTION AND METHOD OF TREATMENT
RU2016143243A (en) ANTITUMEN AGENT CONTAINING A TAXANI COMPOUND AND ANTITUMEN EFFECT AMPLIFIER
EA202191570A1 (en) COMPOSITIONS FOR DELIVERY OF THERAPEUTIC DRUGS, METHODS OF THEIR APPLICATION AND OBTAINING
NZ602655A (en) Preparation for the treatment of equine laminitis